From 9.6 million US diabetic retinopathy cases to a new FDA warning on GLP-1s, here are 5 things to know about diabetic eye disease this November.
|Articles|June 9, 2021
Supplements and Featured Publications
- Moderate to Severe Psoriasis: Considerations for Patient Management Amid a Changing Treatment Spectrum
- Volume 27
- Issue 10
Participating Faculty for Moderate to Severe Psoriasis: Considerations for Patient Management Amid a Changing Treatment Spectrum
Author(s)Jerry Bagel, MD, MS
Advertisement
FACULTY
Jerry Bagel, MD, MS
Director
Psoriasis Treatment Center of New Jersey
East Windsor, New Jersey
Clinical Professor
Icahn School of Medicine at Mount Sinai
New York, New York
FACULTY DISCLOSURES
Jerry Bagel, MD, MS, has disclosed the following relevant commercial financial relationships or affiliations in the past 12 months:
BOARD MEMBERSHIP
The National Psoriasis Foundation, Board of Directors
CONSULTANCIES OR PAID ADVISORY BOARDS
AbbVie, Janssen Pharmaceuticals, Arcutis Biotherapeutics
GRANTS RECEIVED
AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly and Company, Novartis,
Sun Pharma, UCB
LECTURE FEES FOR SPEAKING AT THE INVITATION OF A COMMERCIAL SPONSOR
AbbVie, Eli Lilly and Company, Janssen Pharmaceuticals
Articles in this issue
Advertisement
Related to this article
The action is based on phase 3 VOLGA results, which were presented at the ESMO Congress 2026. They support a perioperative regimen that limits the antibody-drug conjugate to 3 cycles before bladder removal.
New CMS data let EBRI measure what employer plans owe after No Surprises Act arbitration: $8.39B in 2025, though premium impact is unclear.
In this part 2, Kirsten Axelsen, MS, discusses racial disparities, AI in prior authorization, and payers’ readiness for the next wave of CLL therapies.
Kirsten Axelsen, MS, discusses gaps in biomarker testing, nonmedical barriers, and utilization management from a new report on access to CLL care.
A new meta-analysis finds pulmonary rehabilitation and other nonpharmacological interventions ease lung cancer cough, dyspnea, and improve QOL.
Machine learning models for upper extremity soft tissue sarcoma had a C-index of 0.79 for local recurrence, similar to nomograms, in a 188-patient cohort.
Protein intake below 0.6 g/kg/d was linked to a higher risk of kidney failure and death, according to a Korean cohort study.
Advertisement
Advertisement
Trending on AJMC
1
Real-World Cohort Ties JAK Inhibitors in Alopecia Areata to Menstrual Side Effects
2
Phase 3 Trial Tests Ensifentrine for COPD Exacerbation Prevention
3
Tarlatamab Plus Durvalumab Cuts Risk of Death by 58% as First-Line Maintenance in ES-SCLC
4
Trends in Pharmacy Benefit Manager Market Dynamics, 2016-2025
5